DMS (Direct Medical Systems) diagnostic products:
This article was originally published in Clinica
Executive Summary
Direct Medical Systems (DMS) has received US FDA 510(k) market clearance for its DMS-C800 CT scanner and DMS-880P portable B/W ultrasound system. It is the first time that DMS has gained US clearance to sell diagnostic imaging products, a market which the San Ramon, California-based company values at $16bn. The firm's products are already available in other countries. DMS is a joint venture company between several Chinese manufacturers and the government of the People's Republic of China. It is also applying to the FDA for 510(k) clearance for its MRI, mammography, and other ultrasound systems.
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.